Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myelogenous Leukemia in Relapse”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00129168
What this trial is testing

Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia, Myeloid
Kanisa Pharmaceuticals 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06052813
What this trial is testing

BN104 in the Treatment of Acute Leukemia

Who this might be right for
ALL, AdultAML, AdultAcute Leukaemia+4 more
Institut de Recherches Internationales Servier (I.R.I.S.) 66
Early research (Phase 1)Looking for participantsNCT06994676
What this trial is testing

CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Who this might be right for
High-risk Myelodysplastic SyndromeChronic Myelomonocytic Leukemia (CMML)AML - Acute Myeloid Leukemia+1 more
Crossbow Therapeutics, Inc. 72
Testing effectiveness (Phase 2)Study completedNCT00036738
What this trial is testing

Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Blastic Phase+7 more
Fred Hutchinson Cancer Center 28
Early research (Phase 1)Looking for participantsNCT06399640
What this trial is testing

Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

Who this might be right for
Relapsed Myelodysplastic SyndromeRefractory Myelodysplastic SyndromeAcute Myeloid Leukemia+2 more
Vanderbilt-Ingram Cancer Center 60
Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Not applicableLooking for participantsNCT06879847
What this trial is testing

A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 40
Testing effectiveness (Phase 2)Ended earlyNCT06268574
What this trial is testing

Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML

Who this might be right for
Acute Myeloid Leukemia (AML)High-risk Myelodysplastic Syndrome
Ryvu Therapeutics SA 62
Early research (Phase 1)Ended earlyNCT03922477
What this trial is testing

A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Hoffmann-La Roche 13
Testing effectiveness (Phase 2)Study completedNCT02642965
What this trial is testing

Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Post Cytotoxic TherapyRecurrent Childhood Acute Myeloid LeukemiaSecondary Acute Myeloid Leukemia
Children's Oncology Group 38
Testing effectiveness (Phase 2)Study completedNCT01904136
What this trial is testing

Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia With Gene Mutations+6 more
M.D. Anderson Cancer Center 54
Not applicableUnknownNCT04931992
What this trial is testing

Outcome of Patients With CBF and/or NPM1-mutated AML in First Molecular Relapse.

Who this might be right for
Acute Myeloid Leukemia
University Hospital, Angers 100
Early research (Phase 1)Study completedNCT01249430
What this trial is testing

Azacitidine in Combination With Mitoxantrone, Etoposide Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Adult Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00053144
What this trial is testing

Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07722312
What this trial is testing

S243249 Monotherapy in Patients With Relapsed or Refractory Acute Leukemia With a KMT2A or NUP98 Translocation or Relapsed or Refractory AML With NPM1c Mutation

Who this might be right for
Relapsed or Refractory Acute LeukemiaRelapsed or Refractory Acute Myeloid Leukemia
Servier 80
Large-scale testing (Phase 3)Study completedNCT02461537
What this trial is testing

Impact of Remission Induction Chemotherapy Prior to Allogeneic SCT in Relapsed and Poor-response Patients With AML

Who this might be right for
Acute Myeloid Leukemia
DKMS gemeinnützige GmbH 281
Testing effectiveness (Phase 2)Study completedNCT00068718
What this trial is testing

Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant

Who this might be right for
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Adult Acute Myeloid Leukemia+3 more
Fred Hutchinson Cancer Center 35
Early research (Phase 1)Study completedNCT01385423
What this trial is testing

Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 26
Early research (Phase 1)Study completedNCT02071927
What this trial is testing

Study of the Glutaminase Inhibitor CB-839 in Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Lymphocytic Leukemia (ALL)
Calithera Biosciences, Inc 43
Early research (Phase 1)Ended earlyNCT03672851
What this trial is testing

Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Leukemia

Who this might be right for
Acute LeukemiaAcute Leukemia in RelapseAcute Myeloid Leukemia+1 more
Second Affiliated Hospital of Xi'an Jiaotong University 2
Next Page